Christine M. Lovly, MD, PhD Google Scholar: h-index, Total Citations, and Citation Map
Christine M. Lovly, MD, PhD's h-index is 132 (669 i10-index, 68,865+ total citations across 1,000+ publications) according to Google Scholar as of October 2026. Christine M. Lovly, MD, PhD is affiliated with Vanderbilt University Medical Center.
Christine M. Lovly, MD, PhD is a researcher affiliated with Vanderbilt University Medical Center, specializing in cancer. Their work has been cited 68,865 times. This profile visualizes their global influence, highlighting strong citation networks in China.
Christine M. Lovly, MD, PhD's Citation Metrics
Bibliometric impact based on 1,000 indexed publications.
- H-Index
- 132
- i10-Index
- 669
- Total Citations
- 68,865
- Citing Countries
- 40
As of October 2026.
Christine M. Lovly, MD, PhD has an h-index of 132 and 68,865 total citations across 1000 publications, with research cited by institutions in 40 countries.
Download Exports (PNG, CSV, Poster)
Free Viewing Christine M. Lovly, MD, PhD's citation map is always free. Pay once to download poster, PNG, and CSV files for offline use or your visa packet.
Showing partial map from open academic databases
Upgrade ($39.98) for the complete Google Scholar crawl.
Global Impact Map
Visualizing the geographic distribution of institutions that have cited your work.
Starting…
Pins will appear here as institutions are resolved — no need to refresh.
ROS1 Rearrangements Define a Unique Molecular Class of Lung Cancers
20122,126
Top Citing Countries
Top Citing Institutions
Visa Evidence Package
Views and exports tuned for EB-1A, O-1A, and EB-2 NIW petitions. Sustained acclaim, geographic reach, and independent-citation filtering are the strongest evidence categories immigration adjudicators look for.
Citation trend (last 10 years)Click to expand
Citation Trend (Last 10 Years)
Related Guides
Learn how to use citation maps for your research and visa applications.
About Christine M. Lovly, MD, PhD's research
Christine M. Lovly, MD, PhD is a researcher in cancer at Vanderbilt University Medical Center. Their work has been cited 68,865 times across 1,000 publications (h-index 132), according to Google Scholar.
Their most-cited work, “ROS1 Rearrangements Define a Unique Molecular Class of Lung Cancers” (2012), has accumulated 2,126 citations. Other influential works include “Non–small cell lung cancer, version 3.2022, NCCN clinical practice guidelines in oncology” (2022) with 1,542 citations and “Non–small cell lung cancer, version 5.2017, NCCN clinical practice guidelines in oncology” (2017) with 1,379 citations.
Citations of Christine M. Lovly, MD, PhD's research come primarily from China, United States and United Kingdom, reflecting international research impact across 5+ countries. The interactive citation map above shows the full geographic distribution of the institutions citing this work.
